Authorized Generic Drugs: AAI Joins Consumers in Supporting FTC Study

Jun 06 2006
Testimony and Interventions

The AAI signed onto a letter drafted by David Balto of Robins Kaplan Miller & Ciresi LLP on behalf of several consumer groups urging the FTC to go forward with--and broaden the scope of-- its proposed study of authorized generic drugs.

Click here to view this document in Adobe Acrobat format.